Get detailed information on Colchicine, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...
Although the use of i.v. colchicine at UPMC has been minimal, safety guidelines were developed because of the severity of some adverse events. The low therapeutic index, particularly in patients ...
Background: Several anti-inflammatory and urate-lowering drugs commonly used in gout have shown promise in reducing cardiovascular risk. However, there remains controversy regarding the benefits of ...
found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial infarction, stroke, or ischemia-driven revascularization. Findings were reported today at TCT ...
However, residual inflammatory risk may be overlooked. Low-dose colchicine has been shown to reduce stroke and recurrent angina requiring revascularization in clinical trials, but real-world data is ...
Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 ...
As someone who is now using colchicine routinely, these data have changed his opinion, he said. The previous data supporting the use of colchicine "were just so-so," he explained. "Now I have a good ...
Each arm was further randomized to receive spironolactone 25 mg daily or placebo. The current data compare the colchicine and matching placebo arms irrespective of spironolactone use. The primary ...